AUROPHARMA taking support on monthly trend line and 20 dma

Long

AUROBINDO PHARMA (NSE:AUROPHARMA)

Updated

NSE:AUROPHARMA AUROBINDO PHARMA

Trend Analysis Chart Patterns Technical Indicators

trendanalysis chartpattern indicator

its attempt to cross target 1 getting rejected.
with no negative news
if crosses target 1 target 2 and target 3
possible.

Comment:

usa decision to reduce drug prices may have negative impact.
little bad news for pharma companies.

Related Ideas

about AUROPHARMA 3

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.